Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Healthy

Interventions

DRUG

AKB-6548 tablet, reference formulation given in the fasted state

DRUG

AKB-6548 tablet, test formulation given in the fasted state.

DRUG

AKB-6548 tablet, test formulation given in the fed state

Trial Locations (1)

Kalamazoo